Blog @ Fordham IPLJ
Fordham Intellectual Property, Media & Entertainment Law Journal
December 12, 2022
Does an artificial intelligence system have the creative capacity to invent? Perhaps, but according to the Federal Circuit, they do not qualify as “inventors” for the purposes of patent law.
December 9, 2022
Condé Nast, the famous global media company and notable owners of Vogue, the New Yorker, and Vanity Fair among other publications, have sued Drake and 21 Savage after they used
December 8, 2022
Last month, Impossible Foods Inc. beat a motion to dismiss in their lawsuit against Motif Foodworks, Inc. for patent infringement of their plant-based meat products.
December 7, 2022
During the performance of a license agreement, when the beneficiary does not comply with the licensing terms, she might breach the contract and infringe the copyright.
December 6, 2022
“No area of copyright law is more complex, or productive of more controversy over recent decades, than the tangle of copyright rules and industry practices that govern the music industry.”
December 5, 2022
OpenAI’s GPT-3––an autoregressive language model––has generated writing so human-like that novelists and content creators now incorporate it into their writing process. But can AI-generated creativity truly replace the great novelists
December 4, 2022
The video game industry has been consolidating at a rapid pace, with Microsoft’s Activision-Blizzard acquisition being one of the latest examples. This historic merger and the antitrust concerns it raises
December 2, 2022
Why the Supreme Court looks poised to end Section 230 immunity for algorithmic content and friend suggestions with its upcoming case, Gonzalez v. Google.
December 1, 2022
Hailey Bieber’s Rhode brand is being sued for trademark infringement by the fashion label Rhode. Although the fashion label’s motion to preliminarily enjoin Bieber’s brand was denied, the fight is
November 30, 2022
The United States Supreme Court has agreed to review the enablement requirement of the Patent Act for the second time in the law’s history in the dispute between pharmaceutical companies
Loading new posts...
No more posts